Oncosurgery: A new reality in metastatic colorectal carcinoma

Seminars in Oncology

Volumn 29, Issue 5, 2002, Pages 3-10

  Topham, Clare ^a,b   Adam, Reneé ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; OXALIPLATIN; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CRYOSURGERY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LIVER NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0037010094     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(02)90015-1     Document Type: Article

References (53)

1. Cancer Facts & Figures - 2000. Atlanta, GA, American Cancer Society; 2000
2. Cunningham D, Findlay M: The chemotherapy of colon cancer can no longer be ignored. Eur J Cancer 29A:2077-2079, 1993
3. Borner MM: Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer - Too good to be true? Ann Oncol 10:623-626, 1999
4. Fong Y, Cohen AM, Fortner JG, et al: Liver resection for colorectal metastases. J Clin Oncol 15:938-946, 1997
5. Gilbert HA, Kagan AR: Metastases: Incidence, detection, and evaluation without histologic confirmation, in Weiss L (ed): Fundamental Aspects of Metastasis. Amsterdam, North Holland, 1976, pp 385-405
6. André T, Bensmaine MA, Louvet C, et al: Multicenter phase 11 study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17:3560-3568, 1999
7. Ballantyne GH, Quin J: Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252-4266, 1993 (suppl 12)
8. Bleiberg H: Role of chemotherapy for advanced colorectal cancer: New opportunities. Semin Oncol 23:42-50, 1996 (suppl 3)
9. Bismuth H, Adam R, Lévi F, et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-522, 1996
10. Geoghegan JG, Scheele J: Treatment of colorectal liver metastases. Br J Surg 86:158-169, 1999
11. Bleiberg H: Colorectal cancer: The challenge. Eur J Cancer 32A:S2-S6, 1996 (suppl 5)
12. Benson AB III: Therapy for advanced colorectal cancer. Semin Oncol 25:2-11, 1998 (suppl 11)
13. Bismuth H, Adam R: Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy. Semin Oncol 25:40-46, 1998 (suppl 5)
14. Karapetis CS, Yip D, Harper PG: The treatment of metastatic colorectal cancer. Int J Clin Pract 53:287-294, 1999
15. Johnson PJ: Systemic chemotherapy of liver tumors. Semin Surg Oncol 19:116-124, 2000
16. Machover D: A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 80:1179-1187, 1997
17. Jonker DJ, Maroun JA, Kocha W: Survival benefit of chemotherapy in metastatic colorectal cancer: A meta-analysis of randomized controlled trials. Br J Cancer 82:1789-1794, 2000
18. Wilson SM, Adson MA: Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111:330-334, 1976
19. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-321, 1999
20. Jaeck D, Bachellier P, Guiguet M, et al: Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84:977-980, 1997
21. Adam R, Bismuth H, Castaing D, et al: Repeat hepatectomy for colorectal liver metastases. Ann Surg 225:51-62, 1997
22. Kin T, Nakajima Y, Kanehiro H, et al: Repeat hepatectomy for recurrent colorectal metastases. World J Surg 22:1087-1091, 1998
23. Nordlinger B, Vaillant JC, Guiguet M, et al: Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 12:1491-1496, 1994
24. Fernandez-Trigo V, Shamsa F, Sugarbaker PH: Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry. Surgery 117:296-304, 1995
25. Fong Y, Blumgart LH, Cohen A, et al: Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 220:657-662, 1994
26. Neeleman N, Andersson R: Repeated liver resection for recurrent liver cancer. Br J Surg 83:893-901, 1996
27. Tuttle TM, Curley SA, Roh MS: Repeat hepatic resection as effective treatment of recurrent colorectal liver metastases. Ann Surg Oncol 4:125-130, 1997
28. McCarter MD, Fong Y: Metastatic liver tumors. Semin Surg Oncol 19:177-188, 2000
29. Adam R, Akpinar E, Johann M, et al: Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 225:39-50, 1997
30. Finlay IG, Seifert JK, Stewart GJ, et al: Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 26:199-202, 2000
31. Korpan N: Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg 225:193-201, 1997
32. Seifert JK, Achenbach T, Heintz A, et al: Cryotherapy for liver metastases. Int J Colorectal Dis 15:161-166, 2000
33. Weaver ML, Atkinson D, Zemel R: Hepatic cryosurgery in treating colorectal metastases. Cancer 76:210-214, 1995
34. Azoulay D, Castaing D, Smail A, et al: Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480-486, 2000
35. Fiorentini G, Poddie DB, Giorgi UD, et al: Global approach to hepatic metastases from colorectal cancer: Indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 17:163-173, 2000
36. Martin LW, Warren RS: Current management of colorectal liver metastases. Surg Oncol Clin North Am 9:853-878, 2000
37. Pearson AS, Izzo F, Fleming RY, et al: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178:592-599, 1999
38. Adam R, Laurent A, Azoulay D, et al: Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232:777-785, 2000
39. Bertheault-Cvitkovic F, Jami A, Ithzaki M, et al: Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. J Clin Oncol 14:2950-2958, 1996
40. de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
41. Giacchetti S, Perpoint B, Zidani R, et al: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136-147, 2000
42. Levi F, Zidani R, Brienza S, et al: A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. Cancer 85:2532-2540, 1999
43. Giacchetti S, Itzhaki M, Gruia G, et al: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxatiplatin and surgery. Ann Oncol 10:663-669, 1999
44. Adam R, Avisar E, Ariche A, et al: Five years survival after neoadjuvant therapy for non-resectable colorectal liver metastases. Ann Surg Oncol 8:347-353, 2001
45. Lorenz M, Muller HH, Schramm H, et al: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756-762, 1998
46. Kemeny N, Cohen A, Huang Y, et al: Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus SYS alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer. Proc Am Soc Clin Oncol 18:263a, 1999 (abstr 1011)
47. Kemeny MM, Adak S, Lipsitz S, et al: Results of the intergroup (Eastern Cooperative Oncology Group [ECOG] and Southwest Oncology Group [SWOG]) prospective randomized study of surgery alone versus continuous systemic infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection for colorectal liver metastases. Proc Am Soc Clin Oncol 18:264a, 1999 (abstr 1012)
48. Adson MA, van Heerden JA, Adson MH, et al: Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647-651, 1984
49. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multiinstitutional study of patterns of recurrence. Surgery 100:278-284, 1986
50. Doci R, Fennari L, Bignami P, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797-801, 1991
51. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29, 1991
52. Rosen CB, Nagorney DM, Taswell HF, et al: Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:403-504, 1992
53. Nordlinger B, Jaeck D (eds): Traitement des métastases hépatiqes des cancers colorectaux. Monographie de I'Associatio Française de Chirurgie, Paris, France, Springer-Verlag, 1992.